申请人:Bayer Aktiengesellschaft
公开号:US06458796B1
公开(公告)日:2002-10-01
The present invention relates to novel dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one, to processes for their preparation and to their use as medicaments, in particular as inhibitors of cGMP-metabolizing phosphodiesterases.
本发明涉及新型二氢-[1,2,3]三氮唑-[4,5-d]嘧啶-7-酮,以及它们的制备方法和作为药物的用途,特别是作为cGMP代谢磷酸二酯酶的抑制剂。